The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Thoracic Oncology

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JTO.0b013e31815bdc0dPMID 18090577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small cell lung cancer

  2010cited by this paper
• European Organization for Research and Treatment of Cancer (EORTC)

  2008cited by this paper
• Small cell lung cancer.

  2008cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

  2007cited by this paper
• Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan.

  2007cited by this paper
• Lung Cancer: Principles and Practice, 3rd edition.

  2006cited by this paper
• Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.

  2006cited by this paper
• Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

  2006cited by this paper
• Results of surgery in small cell carcinoma of the lung.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising

  2005cited by this paper
• The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors.

  2005cited by this paper
• Impact of adjuvant chemotherapy (CT) on survival and local-control in non-small cell lung cancer (NSCLC): Results of the international adjuvant lung cancer trial (IALT)

  2004cited by this paper
• Should aggressive surgery ever be part of the management of small cell lung cancer?

  2004cited by this paper
• Process of care and preliminary outcome in limited-stage small-cell lung cancer: results of the 1995-1997 patterns of care study in Japan.

  2003cited by this paper
• Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America

  2002cited by this paper
• [Surgical treatment of limited small cell lung cancer].

  2001cited by this paper
• Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan.

  2000cited by this paper
• Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.

  1999cited by this paper
• Design and analysis for survival data under order restrictions with a modified logrank test.

  1998cited by this paper
• North Central Cancer Treatment Group (NCCTG).

  1996cited by this paper
• Eastern Cooperative Oncology Group (ECOG).

  1996cited by this paper
• Lung cancer : principles and practice

  1996cited by this paper
• Testing Against Ordered Alternatives for Censored Survival Data

  1993cited by this paper
• Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.

  1993cited by this paper
• Results of operation without adjuvant therapy in the treatment of small cell lung cancer.

  1992cited by this paper
• Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.

  1991cited by this paper
• Staging and prognostic factors in small cell lung cancer: a consensus report

  1989cited by this paper
• Surgical management of small cell lung cancer: a case report.

  1988cited by this paper
• Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.

  1987cited by this paper
• Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).

  1986cited by this paper
• Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lung.

  1984cited by this paper
• Staging and prognostic factors in small cell carcinoma of the lung.

  1983cited by this paper
• The prospect of disease control by surgery combined with chemotherapy in stage I and stage II small cell carcinoma of the lung.

  1983cited by this paper
• Keynote address on biostatistics and data retrieval.

  1973cited by this paper
• General Thoracic Surgery

  1972cited by this paper

• Factors associated with longer brain metastasis-free survival in limited-disease small-cell lung cancer who underwent concurrent chemoradiotherapy, a retrospective analysis

  2026cites this paper
• Long-term survival in extensive-stage small cell lung cancer: a case report on the integration of interventional bronchoscopy and systemic immunotherapy

  2026cites this paper
• A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer

  2026cites this paper
• Redefining the Fight Against SCLC: Standards, Innovations, and New Horizons

  2025cites this paper
• Kleinzelliges Lungenkarzinom: Aktuelle Standards und Perspektiven in der ­Behandlung

  2025cites this paper
• Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) study.

  2025cites this paper
• The International Association for the Study of Lung Cancer Staging Project: The Database and Proposal for the Revision of the Staging of Pulmonary Neuroendocrine Carcinoma in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.

  2025cites this paper
• Simultaneous Integrated Dose Reduction Radiotherapy Versus Conventional Fractionated Radiotherapy With Chemotherapy for Limited-Stage Small-Cell Lung Cancer in the Modern Treatment Era: a Phase III, Randomized Clinical Trial (SDR-RT trial).

  2025cites this paper
• Prognostic significance of the 9th TNM lung cancer staging system in SCLC

  2025cites this paper
• The profile and clinical predicting effect of non-rash dermatologic toxicity related to targeted therapy in stage-IV non-small cell lung cancer patients.

  2025cites this paper
• Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC

  2024cites this paper
• Prognostic Nomogram for Predicting Survival in Asian Patients With Small‐Cell Lung Cancer: A Comprehensive Population‐Based Study and External Verification

  2024cites this paper
• Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC

  2024cites this paper
• Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR)

  2024cites this paper
• Role of interventional bronchoscopy and chemotherapy in the treatment of patients with small-cell lung cancer: A case report

  2024cites this paper
• Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities

  2024cites this paper
• High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.

  2024cites this paper
• Application of target scanning combined with three-dimensional reconstruction in the diagnosis of early-stage lung adenocarcinoma

  2024cites this paper
• Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations

  2024cites this paper
• Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study

  2024cites this paper
• Number of involved nodal stations predicts survival in small cell lung cancer

  2024cites this paper
• The development and validation of a nomogram for predicting brain metastases after chemotherapy and radiotherapy in male small cell lung cancer patients with stage III

  2023cites this paper
• The effects of surgical resection in the treatment of limited-stage small cell lung cancer: a multicenter retrospective study

  2023cites this paper
• Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

  2023cites this paper
• Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer

  2023cites this paper
• Effect of Segmental Abutting Esophagus-Sparing Technique to Reduce Severe Esophagitis in Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Hypofractionated Thoracic Radiation and Chemotherapy

  2023cites this paper
• Measurements of target volumes and organs at risk using DW‑MRI in patients with central lung cancer accompanied with atelectasis

  2023cites this paper
• The TNM classification of lung cancer—a historic perspective

  2023cites this paper
• The Role of Surgery in Stage I Small Cell Lung Cancer: A National VA Database Analysis.

  2023cites this paper
• Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis

  2023cites this paper
• Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer

  2023cites this paper
• A Review on Small-Cell Lung Cancer: Epidemiology, Pathophysiology, Risk Factors, Diagnosis, Clinical Management and Treatment Modalities

  2023cites this paper
• MicroRNA-613 Enhances Nasopharyngeal Carcinoma Cell Radiosensitivity via the DNA Methyltransferase 3B/Tissue Inhibitor of Matrix Metalloproteinase-3/Signal Transducer and Activator of Transcription-1/Forkhead Box O-1 Axis

  2022cites this paper
• Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis

  2022cites this paper
• The Role of Surgery in High-Grade Neuroendocrine Cancer: Indications for Clinical Practice

  2022cites this paper
• External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer.

  2022cites this paper
• Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens.

  2022cites this paper
• Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review.

  2022cites this paper
• Current therapy and development of therapeutic agents for lung cancer

  2022cites this paper
• One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer

  2022cites this paper
• Clinical Outcomes after Upfront Surgery in Clinical Stage I–IIA Small Cell Lung Cancer

  2022cites this paper
• Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues

  2022cites this paper
• Effect of chromatin modifiers on the plasticity and immunogenicity of small-cell lung cancer

  2022cites this paper
• Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis

  2022cites this paper
• Successful IMRT and concurrent chemotherapy for a patient with intrathoracic extensive‐stage small cell lung cancer

  2022influential citation
• Future Perspectives on the TNM Staging for Lung Cancer

  2021cites this paper
• Behandlung des kleinzelligen Lungenkarzinoms

  2021cites this paper
• LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer

  2021cites this paper
• The current role of surgery and SBRT in early stage of small cell lung cancer

  2021cites this paper
• GOECP/SEOR radiotherapy guidelines for small-cell lung cancer

  2021cites this paper
• Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis

  2021cites this paper
• Role of Key Guidelines in an Era of Precision Oncology: A Primer for the Radiologist.

  2021cites this paper
• circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis

  2021cites this paper
• Surgery in Small-Cell Lung Cancer

  2021cites this paper
• Small-cell lung cancer

  2021cites this paper
• Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy

  2021cites this paper
• High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.

  2021cites this paper
• History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

  2021cites this paper
• Adjuvant treatment for patients with incidentally resected limited disease small cell lung cancer—a retrospective study

  2021cites this paper
• A retrospective analysis of prognostic factors for 160 patients with stage III small cell lung cancer.

  2021cites this paper
• Clinical Impact of Supraclavicular Lymph Node Involvement of Stage IIIC Non-Small Cell Lung Cancer Patients

  2021influential citation
• Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

  2021cites this paper
• Prognostic signi cance of serum osteopontin levels in small-cell lung cancer

  2021cites this paper
• Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis

  2021influential citation
• Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.

  2021cites this paper
• Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer

  2021cites this paper
• Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands.

  2021cites this paper
• Modulation of Signaling Pathways by Immunotherapeutics in Lung Cancer

  2021cites this paper
• Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis

  2021cites this paper
• Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results.

  2021cites this paper
• Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics

  2021cites this paper
• Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors

  2021cites this paper
• Oat Cell Carcinoma Lung Presenting as Chest Wall Swelling

  2021cites this paper
• A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy

  2021cites this paper
• The comparison of SUVmax values in 18F-FDG PET/CT according to cell type, stage, lymph node involvement and metastasis in lung cancers

  2021cites this paper
• Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study

  2021cites this paper
• The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.

  2021cites this paper
• Patterns of Relapse in Small Cell Lung Cancer: Competing Risks of Thoracic versus CNS Relapse

  2021cites this paper
• Is Small Cell Lung Cancer a Surgical Disease at the Present Time?

  2021cites this paper
• Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes

  2021cites this paper
• Akciğer Kanserli Hastalarda F-18 FDG PET/BT Parametrelerinin Klinik Evre ile İlişkisi

  2021cites this paper
• Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer

  2021influential citation
• Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway

  2021cites this paper
• Neuroendocrine Tumors of the Lung

  2020cites this paper
• Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinoma

  2020cites this paper
• Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell Lung Cancer

  2020cites this paper
• The prognostic value of pretreatment prognostic nutritional index in patients with small cell lung cancer and it’s influencing factors: a meta-analysis of observational studies

  2020cites this paper
• Metastatic small cell carcinoma of the lung with prominent spindle cell morphology and hemangiopericytoma-like vascular pattern: A sarcoma mimicker

  2020cites this paper
• The Role of Surgery in Small Cell Lung Carcinoma-Limited Disease

  2020cites this paper
• Metastatic Lymph Node Station Number Predicts Survival in Small Cell Lung Cancer

  2020cites this paper
• Is invasive mediastinal staging necessary in intermediate risk patients with negative PET/CT?

  2020cites this paper
• Prognostic significance of serum osteopontin levels in small cell lung cancer

  2020cites this paper
• Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer

  2020cites this paper
• hTERT promoter methylation promotes small cell lung cancer progression and radiotherapy resistance

  2020cites this paper
• Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer

  2020cites this paper
• Surgery for limited stage small cell lung cancer

  2020cites this paper
• Therapie des kleinzelligen Lungenkarzinoms bei neu diagnostizierten Patienten mit schlechtem Performance-Status

  2020cites this paper
• Current Management and Progress in Radiotherapy for Small Cell Lung Cancer

  2020cites this paper
• Small Cell Lung Cancer: Advances in Diagnosis and Management

  2020cites this paper
• SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy

  2020cites this paper